Bottom line
NMAVX vs IWR: the short answer
NMAVX (Nuance Mid Cap Value Fund) and IWR (iShares Russell Mid-Cap ETF) are both mutual funds.
But IWR is far broader, holding 830 positions to 62 for NMAVX, so beyond the top names it adds exposure NMAVX doesn't have.
IWR is cheaper at 0.18% vs 1.21% — a difference of $103 a year per $10,000 invested.
Over five years, IWR returned +8.5% a year vs +3.1% for NMAVX.
NMAVX has a front-end sales load of up to 5%; the other does not.
Updated Nov 19, 2026
NMAVX vs IWR side by side
| NMAVX | IWR | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | Tortoise | iShares |
| Category | Mid-Cap | Mid-Cap |
| Expense ratio | 1.21% | 0.18% |
| Annual cost per $10k | $121 | $18 |
| 10-yr cost on $10k (prospectus) | $2,002 | $230 |
| Max front load | 5% | None |
| 12b-1 fee | 0.25% | 0% |
| 1-yr return | −1.4% | +10.4% |
| 5-yr return (annualized) | +3.1% | +8.5% |
| 10-yr return (annualized) | +7.6% | +10.8% |
| Best quarter | +15.3% | +24.6% |
| Worst quarter | −19.3% | −27.1% |
| Net assets (fund) | $294.8M | $57.0B |
| Number of holdings | 62 | 830 |
| Portfolio turnover | 11% | 11% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
NMAVX and IWR share none of their top holdings.
NMAVX top 10
- Qiagen Nv — 7.19%
- First American Government Obli — 6.60%
- California Water Service Group — 5.82%
- Beiersdorf AG — 5.70%
- Clorox Co/The — 5.27%
- Kenvue Inc — 3.48%
- Charles Schwab Corp — 3.37%
- Solventum Corp — 3.01%
- Bio-Techne Corp — 2.98%
- Henkel AG & Co KGaA — 2.78%
IWR top 10
- BlackRock Funds III — 2.61%
- Datadog, Inc. — 0.62%
- Snowflake, Inc. — 0.61%
- Royal Caribbean Cruises Ltd. — 0.58%
- Cloudflare, Inc. — 0.56%
- Robinhood Markets, Inc. — 0.56%
- Teradyne, Inc. — 0.55%
- Marathon Petroleum Corp. — 0.54%
- Astera Labs, Inc. — 0.53%
- Simon Property Group, Inc. — 0.52%
FAQ
What is the difference between NMAVX and IWR?
Which is cheaper, NMAVX or IWR?
Should I own both NMAVX and IWR?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.